U.S. drugmaker Pfizer Inc has signed a deal with Germany's BioNTech SE to c...
- U.S. drugmaker Pfizer Inc has signed a deal with Germany’s BioNTech SE to co-develop a potential vaccine for the coronavirus using BioNTech’s mRNA-based drug development platform, the companies said on Tuesday.
The drugmakers will start the collaboration immediately and have signed a letter of intent for the vaccine’s distribution outside China, they said in a joint statement. Reuters reported on Sunday that the German government was trying to stop the U.S. administration from persuading CureVac, another German drugmaker working on an experimental vaccine for the coronavirus, to move its research to the United States.
BioNTech on Monday struck a collaboration deal with Shanghai Fosun Pharmaceutical over its rights in China to its experimental coronavirus vaccine, aiming to start testing on humans from late April.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer Pours All Resources Into Developing New Hyper-Depressant Pill To Help Americans Ease Transition Into Self-QuarantiningNEW YORK—Committing to do everything in their power to help fight the spread of Covid-19, pharmaceutical company Pfizer announced Monday they were pouring all their resources into developing a new hyper-depressant pill to help Americans ease the transition into self-quarantining. “We are actively mobilizing our top scientists to engineer a treatment that will make the long days of staying confined to your homes, shuffling from couch to bathroom, feel not like a CDC-mandated burden, but the only task you’re physically capable of completing,” said Pfizer spokesperson Elaine Barnett, who explained that while participating in social distancing during the pandemic could cause feelings of frustration, the new hyper-depressant pill would help patients achieve a deep state of melancholy so they could better adjust to sitting around doing absolutely nothing. “Within just hours of taking the pill, patients will lose all motivation to get out of bed, eat, pursue and maintain relationships, or hold an interest in the outside world. Bars and restaurants all across the nation are closing, but with just one serotonin-reducing dose, patients won’t want to leave home anyway. And as a positive side effect, patients won’t care that there’s a global pandemic raging worldwide since we’re all staring down the same dull, endless tunnel.” Barnett revealed that the company was also developing dozens of expensive drugs to help manage the effects of the hyper-depressants.
Read more »
Inside One Scientist's Fight to Contain Coronavirus Using DNADr. Kate Broderick, a molecular geneticist, is developing a vaccine to control coronavirus circulating in humans.
Read more »
CureVac CEO interview, coronavirus vaccine development, controversy - Business InsiderEverything you need to know about CureVac, the German drugmaker working on a coronavirus vaccine that's at the heart of a US-German controversy
Read more »
Coronavirus vaccine trial starts Monday, government official saysA clinical trial evaluating a vaccine designed to protect against the new coronavirus will begin Monday.
Read more »
AP Exclusive: Coronavirus vaccine test opens with 1st dosesU.S. researchers gave the first shots in first test of experimental coronavirus vaccine Monday, leading off worldwide hunt for protection as pandemic surges.
Read more »
Regeneron aims to have coronavirus antibody treatment ready for human testing by early summerBiotech giant Regeneron now aims to have doses of a potential COVID-19 drug ready to start human testing by early summer — a significant acceleration of its timeline.
Read more »